vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and PEGASYSTEMS INC (PEGA). Click either name above to swap in a different company.

CLARIVATE PLC is the larger business by last-quarter revenue ($617.0M vs $430.0M, roughly 1.4× PEGASYSTEMS INC). PEGASYSTEMS INC runs the higher net margin — 7.6% vs 0.5%, a 7.1% gap on every dollar of revenue. On growth, CLARIVATE PLC posted the faster year-over-year revenue change (-6.9% vs -9.6%). PEGASYSTEMS INC produced more free cash flow last quarter ($206.5M vs $89.2M). Over the past eight quarters, PEGASYSTEMS INC's revenue compounded faster (10.7% CAGR vs -0.3%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.

CLVT vs PEGA — Head-to-Head

Bigger by revenue
CLVT
CLVT
1.4× larger
CLVT
$617.0M
$430.0M
PEGA
Growing faster (revenue YoY)
CLVT
CLVT
+2.7% gap
CLVT
-6.9%
-9.6%
PEGA
Higher net margin
PEGA
PEGA
7.1% more per $
PEGA
7.6%
0.5%
CLVT
More free cash flow
PEGA
PEGA
$117.3M more FCF
PEGA
$206.5M
$89.2M
CLVT
Faster 2-yr revenue CAGR
PEGA
PEGA
Annualised
PEGA
10.7%
-0.3%
CLVT

Income Statement — Q4 2025 vs Q1 2026

Metric
CLVT
CLVT
PEGA
PEGA
Revenue
$617.0M
$430.0M
Net Profit
$3.1M
$32.8M
Gross Margin
66.8%
75.2%
Operating Margin
6.7%
8.6%
Net Margin
0.5%
7.6%
Revenue YoY
-6.9%
-9.6%
Net Profit YoY
101.6%
-61.6%
EPS (diluted)
$0.00
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
PEGA
PEGA
Q1 26
$430.0M
Q4 25
$617.0M
$504.3M
Q3 25
$623.1M
$381.4M
Q2 25
$621.4M
$384.5M
Q1 25
$593.7M
$475.6M
Q4 24
$663.0M
$490.8M
Q3 24
$622.2M
$325.1M
Q2 24
$650.3M
$351.2M
Net Profit
CLVT
CLVT
PEGA
PEGA
Q1 26
$32.8M
Q4 25
$3.1M
$234.6M
Q3 25
$-28.3M
$43.4M
Q2 25
$-72.0M
$30.1M
Q1 25
$-103.9M
$85.4M
Q4 24
$-191.8M
$119.1M
Q3 24
$-65.6M
$-14.4M
Q2 24
$-304.3M
$6.6M
Gross Margin
CLVT
CLVT
PEGA
PEGA
Q1 26
75.2%
Q4 25
66.8%
79.5%
Q3 25
65.0%
72.2%
Q2 25
67.2%
71.5%
Q1 25
65.1%
78.5%
Q4 24
65.7%
79.1%
Q3 24
66.2%
70.2%
Q2 24
67.2%
72.4%
Operating Margin
CLVT
CLVT
PEGA
PEGA
Q1 26
8.6%
Q4 25
6.7%
20.7%
Q3 25
7.1%
3.8%
Q2 25
1.1%
4.5%
Q1 25
-3.5%
26.7%
Q4 24
-9.4%
29.1%
Q3 24
3.5%
-3.6%
Q2 24
-36.9%
3.7%
Net Margin
CLVT
CLVT
PEGA
PEGA
Q1 26
7.6%
Q4 25
0.5%
46.5%
Q3 25
-4.5%
11.4%
Q2 25
-11.6%
7.8%
Q1 25
-17.5%
18.0%
Q4 24
-28.9%
24.3%
Q3 24
-10.5%
-4.4%
Q2 24
-46.8%
1.9%
EPS (diluted)
CLVT
CLVT
PEGA
PEGA
Q1 26
$0.18
Q4 25
$0.00
$0.81
Q3 25
$-0.04
$0.24
Q2 25
$-0.11
$0.17
Q1 25
$-0.15
$0.91
Q4 24
$-0.27
$1.35
Q3 24
$-0.09
$-0.17
Q2 24
$-0.46
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
PEGA
PEGA
Cash + ST InvestmentsLiquidity on hand
$329.2M
$270.0M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$705.9M
Total Assets
$11.1B
$1.6B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
PEGA
PEGA
Q1 26
$270.0M
Q4 25
$329.2M
$425.8M
Q3 25
$318.7M
$351.4M
Q2 25
$362.6M
$411.6M
Q1 25
$354.0M
$371.7M
Q4 24
$295.2M
$740.0M
Q3 24
$388.5M
$703.0M
Q2 24
$376.4M
$665.1M
Total Debt
CLVT
CLVT
PEGA
PEGA
Q1 26
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Stockholders' Equity
CLVT
CLVT
PEGA
PEGA
Q1 26
$705.9M
Q4 25
$4.8B
$787.4M
Q3 25
$4.9B
$596.8M
Q2 25
$5.0B
$624.5M
Q1 25
$5.0B
$611.3M
Q4 24
$5.1B
$585.5M
Q3 24
$5.5B
$473.0M
Q2 24
$5.6B
$435.4M
Total Assets
CLVT
CLVT
PEGA
PEGA
Q1 26
$1.6B
Q4 25
$11.1B
$1.6B
Q3 25
$11.2B
$1.3B
Q2 25
$11.4B
$1.3B
Q1 25
$11.5B
$1.3B
Q4 24
$11.5B
$1.8B
Q3 24
$12.0B
$1.6B
Q2 24
$12.1B
$1.5B
Debt / Equity
CLVT
CLVT
PEGA
PEGA
Q1 26
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
PEGA
PEGA
Operating Cash FlowLast quarter
$159.9M
Free Cash FlowOCF − Capex
$89.2M
$206.5M
FCF MarginFCF / Revenue
14.5%
48.0%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
51.58×
TTM Free Cash FlowTrailing 4 quarters
$365.3M
$494.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
PEGA
PEGA
Q1 26
Q4 25
$159.9M
$158.4M
Q3 25
$181.1M
$56.3M
Q2 25
$116.3M
$86.3M
Q1 25
$171.2M
$204.2M
Q4 24
$141.3M
$95.2M
Q3 24
$202.9M
$30.5M
Q2 24
$126.2M
$40.1M
Free Cash Flow
CLVT
CLVT
PEGA
PEGA
Q1 26
$206.5M
Q4 25
$89.2M
$152.4M
Q3 25
$115.5M
$51.8M
Q2 25
$50.3M
$84.1M
Q1 25
$110.3M
$202.3M
Q4 24
$59.1M
$92.4M
Q3 24
$126.3M
$27.4M
Q2 24
$60.3M
$38.8M
FCF Margin
CLVT
CLVT
PEGA
PEGA
Q1 26
48.0%
Q4 25
14.5%
30.2%
Q3 25
18.5%
13.6%
Q2 25
8.1%
21.9%
Q1 25
18.6%
42.5%
Q4 24
8.9%
18.8%
Q3 24
20.3%
8.4%
Q2 24
9.3%
11.1%
Capex Intensity
CLVT
CLVT
PEGA
PEGA
Q1 26
Q4 25
11.5%
1.2%
Q3 25
10.5%
1.2%
Q2 25
10.6%
0.6%
Q1 25
10.3%
0.4%
Q4 24
12.4%
0.6%
Q3 24
12.3%
0.9%
Q2 24
10.1%
0.4%
Cash Conversion
CLVT
CLVT
PEGA
PEGA
Q1 26
Q4 25
51.58×
0.68×
Q3 25
1.30×
Q2 25
2.87×
Q1 25
2.39×
Q4 24
0.80×
Q3 24
Q2 24
6.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Academia Government Group$312.3M51%
Re Occurring Revenues$114.1M18%
Life Sciences And Healthcare Group$98.3M16%
Transactional Revenues$97.1M16%

PEGA
PEGA

Pega Cloud$205.0M48%
Subscription license$94.9M22%
Maintenance$75.3M18%
Consulting$54.8M13%

Related Comparisons